期刊： VOX SANGUINIS, 2022; 117 (3)
Background and Objectives We describe the third documented case of autochthonous human babesiosis in Canada and the second in a Canadian blood donor. ......
期刊： VOX SANGUINIS, 2022; 117 (4)
Background and Objectives This study aimed to describe motives as well as donation experiences and the intention to return for further donations of Ge......
期刊： VOX SANGUINIS, 2022; 117 (4)
Background and Objectives Anti-c is the third red blood cell antibody responsible for haemolytic disease of the foetus and newborn (HDFN) requiring in......
期刊： VOX SANGUINIS, 2022; 117 (5)
Background and Objectives Most myelodysplastic syndromes (MDS) patients become red blood cell (RBC) transfusion-dependent. Transfusing MDS patients wi......
期刊： VOX SANGUINIS, 2022; 117 (6)
Background and Objectives Timely and adequate access to safe blood forms an integral part of universal health coverage, but it may be compromised by n......
期刊： VOX SANGUINIS, 2022; 117 (6)
This review, written from the perspective of the plasma industry, discusses plasma procurement and plasma product safety in light of the COVID-19 pand......
期刊： VOX SANGUINIS, 2022; 117 (11)
Background and Objectives Pre-transfusion antibody screening requires the detection and identification of immunoglobulin G (IgG) antibodies against re......
期刊： VOX SANGUINIS, 2022; 117 (10)
Background and Objectives The COVID-19 pandemic has led to a growing interest in hospital-at-home programmes, including home transfusion services. We ......
期刊： VOX SANGUINIS, 2022; 117 (12)
Background and Objectives Adequate supplies of donor blood remain a major challenge in sub-Saharan Africa. This is exacerbated by a lack of confirmato......
期刊： VOX SANGUINIS, 2022; 117 (3)
Background and Objectives Immunoadsorptions (IA) are used to remove autoantibodies from the plasma in autoimmune disorders. In this study, we evaluate......
期刊： VOX SANGUINIS, 2022; 117 (5)
Background and Objectives Australian Red Cross Lifeblood (Lifeblood) performs red blood cell (RBC) antibody screening on every whole blood donation. A......
期刊： VOX SANGUINIS, 2022; 117 (5)
COVID-19 convalescent plasma (CCP) was among the few frontline therapies used to treat COVID-19. After large randomized controlled trials (RCTs) relyi......
